BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bakke I, Qvigstad G, Sandvik AK, Waldum HL. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand J Gastroenterol. 2001;36:1128-1133. [PMID: 11686210 DOI: 10.1080/00365520152584734] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Sun FP, Song YG. G and D cells in rat antral mucosa: an immunoelectron microscopic study. World J Gastroenterol 2003;9:2768-71. [PMID: 14669330 DOI: 10.3748/wjg.v9.i12.2768] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
2 Tømmerås K, Bakke I, Sandvik AK, Larsson E, Waldum HL. Rat parietal cells express CCK2 receptor mRNA: gene expression analysis of single cells isolated by laser-assisted microdissection. Biochemical and Biophysical Research Communications 2002;297:335-40. [DOI: 10.1016/s0006-291x(02)02202-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Waldum HL, Gustafsson B, Fossmark R, Qvigstad G. Antiulcer drugs and gastric cancer. Dig Dis Sci. 2005;50 Suppl 1:S39-S44. [PMID: 16184420 DOI: 10.1007/s10620-005-2805-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
4 Waldum HL, Fossmark R, Bakke I, Martinsen TC, Qvigstad G. Hypergastrinemia in animals and man: causes and consequences. Scand J Gastroenterol 2004;39:505-9. [PMID: 15223671 DOI: 10.1080/00365520410005072] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sandvik AK, Waldum HL, Brenna E. Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections. Expert Opinion on Drug Safety 2005;1:29-38. [DOI: 10.1517/14740338.1.1.29] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
6 Waldum HL, Martinsen TC, Hauso O, Qvigstad G. Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach? Therap Adv Gastroenterol 2010;3:73-6. [PMID: 21180591 DOI: 10.1177/1756283X09357220] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Borch K, Ahrén B, Ahlman H, Falkmer S, Granérus G, Grimelius L. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 2005;242:64-73. [PMID: 15973103 DOI: 10.1097/01.sla.0000167862.52309.7d] [Cited by in Crossref: 193] [Cited by in F6Publishing: 139] [Article Influence: 12.1] [Reference Citation Analysis]
8 Grabowska AM, Morris TM, McKenzie AJ, Kumari R, Hamano H, Emori Y, Yoshinaga K, Watson SA. Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models. Regul Pept 2008;146:46-57. [PMID: 17961733 DOI: 10.1016/j.regpep.2007.08.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
9 Waldum H. Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer. Cancers (Basel) 2021;13:3159. [PMID: 34202596 DOI: 10.3390/cancers13133159] [Reference Citation Analysis]
10 Fossmark R, Zhao C, Martinsen TC, Kawase S, Chen D, Waldum HL. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats. Apmis 2005;113:436-49. [DOI: 10.1111/j.1600-0463.2005.apm_134.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
11 Qvigstad G, Waldum H. Rebound hypersecretion after inhibition of gastric acid secretion. Basic Clin Pharmacol Toxicol. 2004;94:202-208. [PMID: 15125689 DOI: 10.1111/j.1742-7843.2004.pto940502.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
12 Waldum HL, Öberg K, Sørdal ØF, Sandvik AK, Gustafsson BI, Mjønes P, Fossmark R. Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift. Therap Adv Gastroenterol 2018;11:1756284818775054. [PMID: 29872453 DOI: 10.1177/1756284818775054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
13 Waldum HL, Fossmark R. Types of Gastric Carcinomas. Int J Mol Sci. 2018;19. [PMID: 30567376 DOI: 10.3390/ijms19124109] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
14 Gustafsson BI, Bakke I, Hauso Ø, Kidd M, Modlin IM, Fossmark R, Brenna E, Waldum HL. Parietal cell activation by arborization of ECL cell cytoplasmic projections is likely the mechanism for histamine induced secretion of hydrochloric acid. Scand J Gastroenterol 2011;46:531-7. [PMID: 21342027 DOI: 10.3109/00365521.2011.558113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Waldum HL, Hauso Ø, Brenna E, Qvigstad G, Fossmark R. Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man? Scand J Gastroenterol 2016;51:767-73. [PMID: 26872579 DOI: 10.3109/00365521.2016.1143527] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
16 Waldum HL, Sørdal ØF. Classification of Epithelial Malignant Tumors-the Differentiation Between Adenocarcinomas and Neuroendocrine Carcinomas: Why Rely on Nonspecific Histochemistry and Dismiss Specific Methods Like Immunohistochemistry and In Situ Hybridization? Appl Immunohistochem Mol Morphol 2016;24:309-12. [PMID: 26067134 DOI: 10.1097/PAI.0000000000000190] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
17 Boyce M, David O, Darwin K, Mitchell T, Johnston A, Warrington S. Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects. Aliment Pharmacol Ther. 2012;36:181-189. [PMID: 22607579 DOI: 10.1111/j.1365-2036.2012.05143.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
18 Waldum HL, Kleveland PM, Brenna E, Bakke I, Qvigstad G, Martinsen TC, Fossmark R, Gustafsson BI, Sandvik AK. Interactions between gastric acid secretagogues and the localization of the gastrin receptor. Scandinavian Journal of Gastroenterology 2009;44:390-3. [DOI: 10.1080/00365520802624219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Cui GL, Sandvik AK, Munkvold B, Waldum HL. Glycine-extended gastrin-17 stimulates acid secretion only via CCK-2 receptor-induced histamine release in the totally isolated vascularly perfused rat stomach. Acta Physiol Scand. 2002;174:125-130. [PMID: 11860374 DOI: 10.1046/j.1365-201x.2002.00933.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer. 2006;6:936-946. [PMID: 17128210 DOI: 10.1038/nrc2014] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 6.6] [Reference Citation Analysis]
21 Aasarød KM, Waldum HL, Stunes AK, Sandvik AK, Flatberg A, Mjønes P, Syversen U, Bakke I, Fossmark R. Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H+/K+ATPase Beta Subunit Knockout Mice. Int J Mol Sci 2020;21:E927. [PMID: 32023822 DOI: 10.3390/ijms21030927] [Reference Citation Analysis]
22 Waldum H, Mjønes PG. Correct Identification of Cell of Origin May Explain Many Aspects of Cancer: The Role of Neuroendocrine Cells as Exemplified from the Stomach. Int J Mol Sci 2020;21:E5751. [PMID: 32796591 DOI: 10.3390/ijms21165751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Guilloteau P, Le Meuth-Metzinger V, Morisset J, Zabielski R. Gastrin, cholecystokinin and gastrointestinal tract functions in mammals. Nutr Res Rev. 2006;19:254-283. [PMID: 19079889 DOI: 10.1017/S0954422407334082] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Waldum HL, Sørdal ØF, Mjønes PG. The Enterochromaffin-like [ECL] Cell-Central in Gastric Physiology and Pathology. Int J Mol Sci 2019;20:E2444. [PMID: 31108898 DOI: 10.3390/ijms20102444] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
25 Mukawa K, Fujii S, Takeda J, Kitajima K, Tominaga K, Chibana Y, Fujita M, Ichikawa K, Tomita S, Ono Y. Analysis of K-ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors. J Gastroenterol Hepatol. 2005;20:1584-1590. [PMID: 16174078 DOI: 10.1111/j.1440-1746.2005.03897.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
26 Joseph IMP, Zavros Y, Merchant JL, Kirschner D. A model for integrative study of human gastric acid secretion. Journal of Applied Physiology 2003;94:1602-18. [DOI: 10.1152/japplphysiol.00281.2002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
27 Fossmark R, Qvigstad G, Waldum HL. Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia. World J Gastroenterol 2008;14:1646-51. [PMID: 18350594 DOI: 10.3748/wjg.14.1646] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
28 Lerotić I, Baršić N, Stojsavljević S, Duvnjak M. Acid Inhibition and the Acid Rebound Effect. Dig Dis 2011;29:482-6. [DOI: 10.1159/000331514] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
29 Waldum HL, Kleveland PM, Fossmark R. Upper gastrointestinal physiology and diseases. Scand J Gastroenterol 2015;50:649-56. [PMID: 25857514 DOI: 10.3109/00365521.2015.1009157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
30 Fossmark R, Qvigstad G, Martinsen TC, Hauso Ø, Waldum HL. Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis. J Biomed Biotechnol 2011;2011:975479. [PMID: 21127707 DOI: 10.1155/2011/975479] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
31 Sørdal Ø, Waldum H, Nordrum IS, Boyce M, Bergh K, Munkvold B, Qvigstad G. The Gastrin Receptor Antagonist Netazepide (YF476) Prevents Oxyntic Mucosal Inflammation Induced by Helicobacter Pylori Infection in Mongolian Gerbils. Helicobacter 2013;18:397-405. [DOI: 10.1111/hel.12066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
32 Fossmark R, Calvete O, Mjønes P, Benitez J, Waldum HL. ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H(+) K(+) ATPase alpha subunit. APMIS 2016;124:561-6. [PMID: 27150581 DOI: 10.1111/apm.12546] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
33 Aasarød KM, Ramezanzadehkoldeh M, Shabestari M, Mosti MP, Stunes AK, Reseland JE, Beisvag V, Eriksen EF, Sandvik AK, Erben RG, Schüler C, Boyce M, Skallerud BH, Syversen U, Fossmark R. Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice. Journal of Endocrinology 2016;230:251-62. [DOI: 10.1530/joe-16-0017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
34 Martinsen TC, Bakke I, Chen D, Sandvik AK, Zahlsen K, Aamo T, Waldum HL. Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-α. American Journal of Physiology-Gastrointestinal and Liver Physiology 2005;289:G1052-60. [DOI: 10.1152/ajpgi.00268.2005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Martinsen TC, Fossmark R, Waldum HL. The Phylogeny and Biological Function of Gastric Juice-Microbiological Consequences of Removing Gastric Acid. Int J Mol Sci 2019;20:E6031. [PMID: 31795477 DOI: 10.3390/ijms20236031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
36 Shulkes A, Baldwin GS, Giraud AS. Regulation of Gastric Acid Secretion. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 1223-58. [DOI: 10.1016/b978-012088394-3/50052-0] [Cited by in Crossref: 11] [Article Influence: 0.7] [Reference Citation Analysis]
37 Waldum H, Mjønes P. Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells. Cancers (Basel) 2020;12:E3477. [PMID: 33266504 DOI: 10.3390/cancers12113477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Waldum HL. The increase in early-onset gastric carcinomas from 1995 is probably due to the introduction of proton pump inhibitors. Surgery 2020;168:568-9. [PMID: 32122656 DOI: 10.1016/j.surg.2020.01.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
39 Misund K, Selvik LK, Rao S, Nørsett K, Bakke I, Sandvik AK, Lægreid A, Bruland T, Prestvik WS, Thommesen L. NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells. PLoS One 2013;8:e76234. [PMID: 24086717 DOI: 10.1371/journal.pone.0076234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
40 Fossmark R, Sagatun L, Nordrum IS, Sandvik AK, Waldum HL. Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival. APMIS. 2015;123:509-514. [PMID: 25939315 DOI: 10.1111/apm.12380] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
41 Waldum HL, Hauso Ø, Sørdal ØF, Fossmark R. Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach. Dig Dis Sci 2015;60:1522-7. [DOI: 10.1007/s10620-014-3468-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
42 Sheng W, Malagola E, Nienhüser H, Zhang Z, Kim W, Zamechek L, Sepulveda A, Hata M, Hayakawa Y, Zhao CM, Chen D, Wang TC. Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation. Cell Mol Gastroenterol Hepatol 2020;10:434-449.e1. [PMID: 32330731 DOI: 10.1016/j.jcmgh.2020.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
43 Waldum HL. Clinical consequences of controversies in gastric physiology. Scand J Gastroenterol 2020;55:752-8. [PMID: 32515242 DOI: 10.1080/00365521.2020.1771758] [Reference Citation Analysis]
44 Fjeldbo CS, Bakke I, Erlandsen SE, Holmseth J, Lægreid A, Sandvik AK, Thommesen L, Bruland T. Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;302:G21-33. [DOI: 10.1152/ajpgi.00197.2011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
45 Sundaresan S, Kang AJ, Hayes MM, Choi EK, Merchant JL. Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids. Gut. 2016; Feb 9. [Epub ahead of print]. [PMID: 26860771 DOI: 10.1136/gutjnl-2015-310928] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
46 Zhao CM, Martinez V, Piqueras L, Wang L, Taché Y, Chen D. Control of gastric acid secretion in somatostatin receptor 2 deficient mice: shift from endocrine/paracrine to neurocrine pathways. Endocrinology 2008;149:498-505. [PMID: 17974627 DOI: 10.1210/en.2007-0238] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
47 Waldum HL, Hauso Ø, Fossmark R. The regulation of gastric acid secretion - clinical perspectives. Acta Physiol (Oxf). 2014;210:239-256. [PMID: 24279703 DOI: 10.1111/apha.12208] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
48 Helgadottir H, Bjornsson ES. Problems Associated with Deprescribing of Proton Pump Inhibitors. Int J Mol Sci 2019;20:E5469. [PMID: 31684070 DOI: 10.3390/ijms20215469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Waldum HL, Kleveland PM, Sandvik AK, Brenna E, Syversen U, Bakke I, Tømmerås K. The cellular localization of the cholecystokinin 2 (gastrin) receptor in the stomach. Pharmacol Toxicol 2002;91:359-62. [PMID: 12688379 DOI: 10.1034/j.1600-0773.2002.910613.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
50 Waldum HL, Fossmark R. Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man. Gut 2018;67:199-200. [PMID: 29158236 DOI: 10.1136/gutjnl-2017-315629] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
51 Schubert ML. Gastric secretion. Curr Opin Gastroenterol 2002;18:639-49. [PMID: 17033342 DOI: 10.1097/00001574-200211000-00002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
52 Waldum HL, Qvigstad G, Fossmark R, Kleveland PM, Sandvik AK. Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scandinavian Journal of Gastroenterology 2010;45:389-94. [DOI: 10.3109/00365520903477348] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
53 Mjønes P, Nordrum IS, Sørdal Ø, Sagatun L, Fossmark R, Sandvik A, Waldum HL. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells. Horm Cancer 2018;9:40-54. [PMID: 28980157 DOI: 10.1007/s12672-017-0311-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]